ASENT 2021 is the premier neuroscience and neurotherapeutics conference where senior leaders from leading payers, providers, employers, investors, fast-growing startups, pharma, policymakers, funders and innovation centers gather to ask one question: how can we improve the process of bringing neurotherapeutics to market? The ASENT 2021 conference will focus on the latest science in neurotherapeutics including innovations across disease states, novel delivery systems, gene therapy and biomarkers, and of course the latest drug therapies and devices. The event features plenary sessions, panel discussions, networking meetings, outstanding pipeline presentations and poster sessions.

WHO ATTENDS

Chief Medical Officers | CEOs | Founders |Funders | Investors | Innovation Centers | Journal Editors | Drug and Device Companies | Communication Companies | Health Systems | Chairs of Neurology | Executive Directors | FDA | NINDS | NIMH | NIA

WHAT IS ASENT

The American Society for Experimental Neurotherapeutics (ASENT) is an independent non-profit organization established in 1997 by leaders in academia, government, advocacy and industry to facilitate the process by which new therapies are made available to patients with neurological disorders. Its primary goal is to encourage and advance the development of improved therapies for diseases and disorders of the nervous system.